Report Detail
Global (United States, European Union and China) Receptor Tyrosine Protein Kinase Targeted Drugs Market Research Report 2019-2025
- RnM3334617 |
- 21 April, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Receptor Tyrosine Protein Kinase Targeted Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Receptor Tyrosine Protein Kinase Targeted Drugs.
This report studies the global market size of Receptor Tyrosine Protein Kinase Targeted Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Receptor Tyrosine Protein Kinase Targeted Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Aslan Pharmaceuticals Pte Ltd
Boehringer Ingelheim GmbH
GamaMabs Pharma SA
Hanmi Pharmaceuticals Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Minerva Neurosciences Inc
Pfizer Inc
Puma Biotechnology Inc
Shanghai Fosun Pharmaceutical (Group) Co Ltd
XuanZhu Pharma Co Ltd
Zensun (Shanghai) Sci & Tech Co Ltd
Market Segment by Product Type
Afatinib Dimaleate
Dacomitinib
Neratinib
Neucardin
Others
Market Segment by Application
Oncology
Cardiovascular
Central Nervous System
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Receptor Tyrosine Protein Kinase Targeted Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Receptor Tyrosine Protein Kinase Targeted Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Receptor Tyrosine Protein Kinase Targeted Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Afatinib Dimaleate
- 1.3.3 Dacomitinib
- 1.3.4 Neratinib
- 1.3.5 Neucardin
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application (2019-2025)
- 1.4.2 Oncology
- 1.4.3 Cardiovascular
- 1.4.4 Central Nervous System
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size
- 2.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue 2014-2025
- 2.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales 2014-2025
- 2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Growth Rate by Regions
- 2.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Regions 2014-2019
- 2.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Manufacturers
- 3.1.1 Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Receptor Tyrosine Protein Kinase Targeted Drugs Price by Manufacturers
- 3.4 Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market
- 3.6 Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Afatinib Dimaleate Sales and Revenue (2014-2019)
- 4.1.2 Dacomitinib Sales and Revenue (2014-2019)
- 4.1.3 Neratinib Sales and Revenue (2014-2019)
- 4.1.4 Neucardin Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type
- 4.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Type
- 4.4 Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application
6 United States
- 6.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Company
- 6.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Type
- 6.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Company
- 7.2 European Union Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Type
- 7.3 European Union Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Application
8 China
- 8.1 China Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Company
- 8.2 China Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Type
- 8.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Company
- 9.2 Rest of World Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Type
- 9.3 Rest of World Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Application
- 9.4 Rest of World Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries
- 9.4.2 Rest of World Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Aslan Pharmaceuticals Pte Ltd
- 10.1.1 Aslan Pharmaceuticals Pte Ltd Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.1.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.1.5 Aslan Pharmaceuticals Pte Ltd Recent Development
- 10.2 Boehringer Ingelheim GmbH
- 10.2.1 Boehringer Ingelheim GmbH Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.2.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.2.5 Boehringer Ingelheim GmbH Recent Development
- 10.3 GamaMabs Pharma SA
- 10.3.1 GamaMabs Pharma SA Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.3.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.3.5 GamaMabs Pharma SA Recent Development
- 10.4 Hanmi Pharmaceuticals Co Ltd
- 10.4.1 Hanmi Pharmaceuticals Co Ltd Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.4.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.4.5 Hanmi Pharmaceuticals Co Ltd Recent Development
- 10.5 Jiangsu Kanion Pharmaceutical Co Ltd
- 10.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.5.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Recent Development
- 10.6 Minerva Neurosciences Inc
- 10.6.1 Minerva Neurosciences Inc Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.6.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.6.5 Minerva Neurosciences Inc Recent Development
- 10.7 Pfizer Inc
- 10.7.1 Pfizer Inc Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.7.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.7.5 Pfizer Inc Recent Development
- 10.8 Puma Biotechnology Inc
- 10.8.1 Puma Biotechnology Inc Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.8.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.8.5 Puma Biotechnology Inc Recent Development
- 10.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
- 10.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.9.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development
- 10.10 XuanZhu Pharma Co Ltd
- 10.10.1 XuanZhu Pharma Co Ltd Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs
- 10.10.4 Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction
- 10.10.5 XuanZhu Pharma Co Ltd Recent Development
- 10.11 Zensun (Shanghai) Sci & Tech Co Ltd
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Receptor Tyrosine Protein Kinase Targeted Drugs Sales Channels
- 11.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Distributors
- 11.3 Receptor Tyrosine Protein Kinase Targeted Drugs Customers
12 Market Forecast
- 12.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Type
- 12.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application
- 12.4 Receptor Tyrosine Protein Kinase Targeted Drugs Forecast by Regions
- 12.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Receptor Tyrosine Protein Kinase Targeted Drugs. Industry analysis & Market Report on Receptor Tyrosine Protein Kinase Targeted Drugs is a syndicated market report, published as Global (United States, European Union and China) Receptor Tyrosine Protein Kinase Targeted Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
